Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000053417-25-000052·Arcutis Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Common Stock · CUSIP: 03969K108
Event date: 2025-03-31
- Filing-level shares
- 11,360,875
- Percent of class
- 9.6%
- Jennison Associates LLC
Shares: 11,360,875 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-25-000052
- Form type
- SCHEDULE 13G/A
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- May 08, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership